Medplus Health Services Ltd
Company Profile
Business description
Medplus Health Services Ltd and its subsidiaries are mainly engaged in the retail trading of medicines and general merchandise; wholesale cash-and-carry operations; the provision of diagnostic, pathological, and laboratory testing services; and the wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods, and beauty products. The Group's product portfolio includes essential items such as medications, vitamins, medical devices, home and personal care products, toiletries, baby care essentials, soaps, detergents, as well as sanitizers, among others. These products are mainly sold through a network of retail stores spread across India. The Group's reportable segments are: Retail, which generates maximum revenue, Diagnostics, and Others.
Contact
Survey No. 257 and 258/1
H. No. 11-6-56, Moosapet
Opposite IDPL Railway Siding
Kukatpally
HyderabadTG500037
INDT: +91 4067246724
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 March 2027
Employees
27,686
Stocks News & Analysis
stocks
ASX healthcare share remains undervalued ahead of earnings
stocks
Alphabet earnings: Strong AI monetization continues to spearhead results
stocks
AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,941.50 | 32.70 | -0.36% |
| CAC 40 | 8,372.28 | 0.00 | 0.00% |
| DAX 40 | 25,099.00 | 335.88 | 1.36% |
| Dow JONES (US) | 51,947.25 | 235.60 | 0.46% |
| FTSE 100 | 10,736.23 | 97.06 | 0.91% |
| HKSE | 24,963.23 | 247.58 | -0.98% |
| NASDAQ | 24,975.82 | 161.87 | -0.64% |
| Nikkei 225 | 64,611.15 | 1,811.45 | -2.73% |
| NZX 50 Index | 13,772.29 | 23.02 | -0.17% |
| S&P 500 | 7,411.98 | 3.68 | 0.05% |
| S&P/ASX 200 | 8,772.30 | 23.40 | -0.27% |
| SSE Composite Index | 3,814.20 | 62.58 | -1.61% |